pyrazolanthrone has been researched along with h 89 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Hanada, K; Iwasaki, Y; Kageyama, K; Nigawara, T; Sakihara, S; Suda, T; Takayasu, S | 1 |
| Boulukos, K; Clavel, S; Coldefy, AS; Dérijard, B; Pisani, DF; Siffroi-Fernandez, S | 1 |
| Fernández-Galilea, M; Martinez, JA; Moreno-Aliaga, MJ; Pérez-Matute, P; Prieto-Hontoria, PL | 1 |
| Cao, JP; Chen, CQ; Jiang, ZM; Li, CL; Lin, D; Liu, S; Ma, DC; Pu, FF; Xing, SN; Yang, JG; Zhao, S; Zhao, YS | 1 |
| Li, C; Liu, S; Ma, D; Pu, F; Xing, S; Yang, J; Yu, Y; Zhao, S | 1 |
| Li, C; Liu, S; Ma, D; Wang, L; Xing, S; Yang, J; Yu, Y; Zhao, S | 1 |
10 other study(ies) available for pyrazolanthrone and h 89
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Involvement of regulatory elements on corticotropin-releasing factor gene promoter in hypothalamic 4B cells.
Topics: Anthracenes; Cell Line; Chromones; Colforsin; Corticotropin-Releasing Hormone; Dexamethasone; Flavonoids; Genes, Reporter; Humans; Hypothalamus; Imidazoles; Isoquinolines; Morpholines; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pyridines; Regulatory Elements, Transcriptional; Sequence Deletion; Sulfonamides; Transfection | 2008 |
Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells.
Topics: Animals; Anthracenes; Cell Line; Cell Nucleus; Chromones; Exportin 1 Protein; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Isoquinolines; Karyopherins; MAP Kinase Kinase 3; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Muscle Cells; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Cytoplasmic and Nuclear; Signal Transduction; SKP Cullin F-Box Protein Ligases; Sulfonamides; Thiophenes; Transfection | 2010 |
Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anthracenes; Carrier Proteins; Chromones; Isoquinolines; JNK Mitogen-Activated Protein Kinases; Lipase; Lipolysis; Mice; Morpholines; Perilipin-1; Phosphoproteins; Phosphorylation; Quinolones; Ribonucleotides; Sterol Esterase; Sulfonamides; Thioctic Acid | 2012 |
Phosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell lines.
Topics: Anthracenes; Cell Line; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Humans; Isoquinolines; Megakaryocytes; Models, Molecular; Molecular Conformation; Mutation; Phosphorylation; Polyploidy; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 70-kDa; Sulfonamides | 2014 |
[Protein kinase A inhibitor H-89 blocks polyploidization of SP600125-induced CMK cells by regulating phosphorylation of ribosomal protein S6 kinase 1].
Topics: Anthracenes; Cell Line; Humans; Isoquinolines; Megakaryocytes; Molecular Docking Simulation; Phosphorylation; Polyploidy; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Sulfonamides | 2016 |
[SP600125-induced polyploidization of megakaryocytic leukemia cell lines by ribosomal protein S6 kinase 1 depends on the degree of cell differentiation].
Topics: Anthracenes; Cell Differentiation; Cell Line; Humans; Isoquinolines; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Phosphorylation; Polyploidy; Ribosomal Protein S6 Kinases; Sulfonamides | 2016 |